Skip to main content
Top
Published in: Endocrine 1/2013

01-02-2013 | Original Article

Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan

Authors: Rana Dajani, Yousef S. Khader, Nancy Hakooz, Raja Fatahalla, Farouk Quadan

Published in: Endocrine | Issue 1/2013

Login to get access

Abstract

The prevalence of metabolic syndrome is increasing worldwide and exhibits variation among ethnic groups. The objective of this study was to estimate and compare the prevalence of metabolic syndrome and its components between two ethnic groups (Circassians and Chechens) in Jordan and the original inhabitants of Jordan. Data were collected from a cross-sectional study of Circassian (n = 436), Chechen (n = 355), and Jordanian (n = 3234) population aged 18 years and older. Metabolic syndrome was defined according to International Diabetes Federation criteria. Age-standardized prevalence rate of metabolic syndrome was Jordanians 38.0 %, Circassians 32.0 %, and Chechens 33.7 %. Compared to Jordanians, both minority groups had lower means of body mass index, total cholesterol, fasting blood glucose, and triglycerides. The means of high-density lipoprotein and low-density lipoprotein were significantly higher among Circassians compared to Jordanians and Chechens. The odds of BMI defined by overweight and obesity and diabetes were less common among Circassians and Chechens compared to Jordanians. The prevalence of the metabolic syndrome and its individual components is relatively high in the three ethnic groups compared to world. Variation in components between groups may relate to ethnicity. Therefore, a community-based integrated approach is needed that would include behavioral, social changes that would lead to the prevention and treatment of the metabolic syndrome.
Literature
1.
go back to reference WHO, W.H.O.: Core Health Indicators. World Health Statistics In. (2006) WHO, W.H.O.: Core Health Indicators. World Health Statistics In. (2006)
2.
go back to reference Ministry of Health, T.H.K.o.J., Mortality in Jordan (Ministry of Health, The Hashemite Kingdom of Jordan, Amman, 2008) Ministry of Health, T.H.K.o.J., Mortality in Jordan (Ministry of Health, The Hashemite Kingdom of Jordan, Amman, 2008)
3.
go back to reference K. Ajlouni, Y.S. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, An increase in prevalence of diabetes mellitus in Jordan over 10 years. J. Diabetes Complicat. 22(5), 317–324 (2008)PubMedCrossRef K. Ajlouni, Y.S. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, An increase in prevalence of diabetes mellitus in Jordan over 10 years. J. Diabetes Complicat. 22(5), 317–324 (2008)PubMedCrossRef
4.
go back to reference Y. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, K. Ajlouni, Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab. Syndr. Relat. Disord. 6(2), 113–120 (2008)PubMedCrossRef Y. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, K. Ajlouni, Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab. Syndr. Relat. Disord. 6(2), 113–120 (2008)PubMedCrossRef
5.
go back to reference F.M. Mubarak, E.S. Froelicher, H.Y. Jaddou, K.M. Ajlouni, Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann. Saudi Med. 28(5), 346–351 (2008)PubMedCrossRef F.M. Mubarak, E.S. Froelicher, H.Y. Jaddou, K.M. Ajlouni, Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann. Saudi Med. 28(5), 346–351 (2008)PubMedCrossRef
6.
go back to reference Y.S. Khader, A. Batieha, M. El-Khateeb, M. Al Omari, K. Ajlouni, Prevalence of dyslipidemia and its associated factors among Jordanian adults. J. Clin. Lipidol. 4(1), 53–58 (2010)PubMedCrossRef Y.S. Khader, A. Batieha, M. El-Khateeb, M. Al Omari, K. Ajlouni, Prevalence of dyslipidemia and its associated factors among Jordanian adults. J. Clin. Lipidol. 4(1), 53–58 (2010)PubMedCrossRef
7.
go back to reference Y. Khader, A. Bateiha, M. El-Khateeb, A. Al-Shaikh, K. Ajlouni, High prevalence of the metabolic syndrome among Northern Jordanians. J. Diabetes Complicat. 21(4), 214–219 (2007)PubMedCrossRef Y. Khader, A. Bateiha, M. El-Khateeb, A. Al-Shaikh, K. Ajlouni, High prevalence of the metabolic syndrome among Northern Jordanians. J. Diabetes Complicat. 21(4), 214–219 (2007)PubMedCrossRef
9.
go back to reference G. Barbujani, I.S. Nasidze, G.N. Whitehead, Genetic diversity in the Caucasus. Hum. Biol. 66(4), 639–668 (1994)PubMed G. Barbujani, I.S. Nasidze, G.N. Whitehead, Genetic diversity in the Caucasus. Hum. Biol. 66(4), 639–668 (1994)PubMed
10.
go back to reference W. Richmond, The Northwest Caucasus: Past, Present, Future, vol. 12. Central Asian Studies Series Routledge (Routledge Press, Routledge, 2008) W. Richmond, The Northwest Caucasus: Past, Present, Future, vol. 12. Central Asian Studies Series Routledge (Routledge Press, Routledge, 2008)
11.
go back to reference K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009)PubMedCrossRef K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009)PubMedCrossRef
12.
go back to reference Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163(4), 427–436 (2003)PubMedCrossRef Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163(4), 427–436 (2003)PubMedCrossRef
13.
go back to reference L.A. Jaber, M.B. Brown, A. Hammad, Q. Zhu, W.H. Herman, The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 27(1), 234–238 (2004)PubMedCrossRef L.A. Jaber, M.B. Brown, A. Hammad, Q. Zhu, W.H. Herman, The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 27(1), 234–238 (2004)PubMedCrossRef
14.
go back to reference H.F. Abdul-Rahim, A. Husseini, E. Bjertness, R. Giacaman, N.H. Gordon, J. Jervell, The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 24(2), 275–279 (2001)PubMedCrossRef H.F. Abdul-Rahim, A. Husseini, E. Bjertness, R. Giacaman, N.H. Gordon, J. Jervell, The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 24(2), 275–279 (2001)PubMedCrossRef
15.
go back to reference J.A. Al-Lawati, A.J. Mohammed, H.Q. Al-Hinai, P. Jousilahti, Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26(6), 1781–1785 (2003)PubMedCrossRef J.A. Al-Lawati, A.J. Mohammed, H.Q. Al-Hinai, P. Jousilahti, Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26(6), 1781–1785 (2003)PubMedCrossRef
16.
go back to reference A.K. Ozsahin, A. Gokcel, N. Sezgin, M. Akbaba, N. Guvener, L. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17(4), 230–234 (2004)PubMed A.K. Ozsahin, A. Gokcel, N. Sezgin, M. Akbaba, N. Guvener, L. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17(4), 230–234 (2004)PubMed
17.
go back to reference F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 61(1), 29–37 (2003)PubMedCrossRef F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 61(1), 29–37 (2003)PubMedCrossRef
18.
go back to reference A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60(3), 199–204 (2003)PubMedCrossRef A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60(3), 199–204 (2003)PubMedCrossRef
19.
go back to reference D.B. Carr, K.M. Utzschneider, R.L. Hull, K. Kodama, B.M. Retzlaff, J.D. Brunzell, J.B. Shofer, B.E. Fish, R.H. Knopp, S.E. Kahn, Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53(8), 2087–2094 (2004)PubMedCrossRef D.B. Carr, K.M. Utzschneider, R.L. Hull, K. Kodama, B.M. Retzlaff, J.D. Brunzell, J.B. Shofer, B.E. Fish, R.H. Knopp, S.E. Kahn, Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53(8), 2087–2094 (2004)PubMedCrossRef
20.
go back to reference C.H. Tsai, T.C. Li, C.C. Lin, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40(2), 256–264 (2011)PubMedCrossRef C.H. Tsai, T.C. Li, C.C. Lin, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40(2), 256–264 (2011)PubMedCrossRef
21.
go back to reference A. Esteghamati, A. Zandieh, O. Khalilzadeh, A. Morteza, A. Meysamie, M. Nakhjavani, M.M. Gouya, Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine 38(2), 206–213 (2010)PubMedCrossRef A. Esteghamati, A. Zandieh, O. Khalilzadeh, A. Morteza, A. Meysamie, M. Nakhjavani, M.M. Gouya, Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine 38(2), 206–213 (2010)PubMedCrossRef
22.
go back to reference S. Taslim, E.S. Tai, The relevance of the metabolic syndrome. Ann. Acad. Med. Singapore 38(1), 29–30 (2009)PubMed S. Taslim, E.S. Tai, The relevance of the metabolic syndrome. Ann. Acad. Med. Singapore 38(1), 29–30 (2009)PubMed
23.
go back to reference H.N. Ginsberg, P.R. MacCallum, The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J. Cardiometab. Syndr. 4(2), 113–119 (2009)PubMedCrossRef H.N. Ginsberg, P.R. MacCallum, The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J. Cardiometab. Syndr. 4(2), 113–119 (2009)PubMedCrossRef
Metadata
Title
Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan
Authors
Rana Dajani
Yousef S. Khader
Nancy Hakooz
Raja Fatahalla
Farouk Quadan
Publication date
01-02-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9723-y

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine